SecSonar.com

Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Lifecore Biomedical, Inc. (LFCR) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $187.5M. Revenue grew 0.5% year-over-year and free cash flow was negative at -$13.6M. This page tracks LFCR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 524 employees · IPO Feb 15, 1996

Valuation

Valuation & price

$4.40 · as of May 17, 2026 · -50.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

140.38

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.67$6.17$3.66Jul 25Dec 25Jul 26Jul 7, 25$8.22Jul 9, 25$8.15Jul 11, 25$8.30Jul 15, 25$7.69Jul 17, 25$7.68Jul 21, 25$7.46Jul 23, 25$7.53Jul 25, 25$7.43Jul 29, 25$7.22Jul 31, 25$7.00Aug 4, 25$7.41Aug 6, 25$7.73Aug 11, 25$7.22Aug 13, 25$7.74Aug 15, 25$7.37Aug 19, 25$7.25Aug 21, 25$7.22Aug 25, 25$7.59Aug 27, 25$7.53Aug 29, 25$7.61Sep 3, 25$7.71Sep 5, 25$7.53Sep 9, 25$7.26Sep 11, 25$7.77Sep 16, 25$7.86Sep 18, 25$7.93Sep 22, 25$7.88Sep 24, 25$7.06Sep 26, 25$7.01Sep 30, 25$7.36Oct 2, 25$7.06Oct 6, 25$6.85Oct 8, 25$6.87Oct 10, 25$6.50Oct 14, 25$6.54Oct 16, 25$6.53Oct 21, 25$6.76Oct 23, 25$6.81Oct 27, 25$6.73Oct 29, 25$7.06Oct 31, 25$7.19Nov 4, 25$6.78Nov 6, 25$6.62Nov 10, 25$7.29Nov 12, 25$8.22Nov 14, 25$7.96Nov 18, 25$7.60Nov 20, 25$7.37Nov 25, 25$7.90Nov 28, 25$7.90Dec 2, 25$7.72Dec 4, 25$7.77Dec 8, 25$7.51Dec 10, 25$7.63Dec 12, 25$7.79Dec 16, 25$7.71Dec 18, 25$8.42Dec 22, 25$8.17Dec 24, 25$8.25Dec 29, 25$8.25Jan 2, 26$7.74Jan 6, 26$7.91Jan 8, 26$7.77Jan 12, 26$7.59Jan 14, 26$7.88Jan 16, 26$8.22Jan 21, 26$8.43Jan 23, 26$8.58Jan 27, 26$8.67Jan 29, 26$8.51Feb 2, 26$8.52Feb 4, 26$7.90Feb 9, 26$7.46Feb 11, 26$7.23Feb 13, 26$7.08Feb 18, 26$7.26Feb 20, 26$7.13Feb 24, 26$7.22Feb 26, 26$7.37Mar 2, 26$7.23Mar 4, 26$7.06Mar 6, 26$6.96Mar 10, 26$6.90Mar 12, 26$6.61Mar 17, 26$4.36Mar 19, 26$4.06Mar 23, 26$4.05Mar 25, 26$4.19Mar 27, 26$3.66Mar 31, 26$3.72Apr 2, 26$3.84Apr 7, 26$4.11Apr 9, 26$4.72Apr 13, 26$4.94Apr 15, 26$5.38Apr 17, 26$5.38Apr 22, 26$5.23Apr 24, 26$5.02Apr 28, 26$5.12Apr 30, 26$5.07May 4, 26$5.13May 6, 26$4.96May 8, 26$4.79May 12, 26$4.56May 14, 26$4.55May 18, 26$4.38May 20, 26$4.57May 22, 26$4.93May 28, 26$4.97Jun 1, 26$4.85Jun 3, 26$5.67Jun 5, 26$5.63Jun 9, 26$5.66Jun 11, 26$5.65Jun 15, 26$5.49Jun 17, 26$5.52Jun 22, 26$5.53Jun 24, 26$5.80Jun 26, 26$5.17Jul 2, 26$5.09
$3.6652-week range$8.82
Loading valuation history…

Fundamentals

Key fundamentals

$187.5M

Market cap

0.5%

Revenue growth (YoY)

31.3%

Gross margin

-$13.6M

Free cash flow (USD)

$122.6M

Net debt

14.3%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$541.1MFY 2017$532.3MFY 2018$524.2MFY 2019$557.6MFY 2020$160.1MFY 2021$100.9MFY 2022$111.3MFY 2023$103.3MFY 2024$128.3MFY 2025$128.9M
$541.1M$128.9M

Free cash flow by year

2016 → 2025

FY 2016$-19.1MFY 2017$6.7MFY 2018$-13.8MFY 2019$-28.7MFY 2020$-43.7MFY 2021$-8.8MFY 2022$-52.5MFY 2023$-38.9MFY 2024$-18.1MFY 2025$-13.6M
-$19.1M-$13.6M

Gross margin by year

2021 → 2025

FY 202138.6%FY 202235.1%FY 202327.1%FY 202432.6%FY 202531.3%
38.6%31.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventSeries A Preferred Stock RedemptionJul 2, 2026Filing
  • 8-K eventStock Incentive Plan AdoptionJun 5, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is Lifecore Biomedical, Inc.'s market cap?

Lifecore Biomedical, Inc. (LFCR) has a market capitalization of $187.5M.

What is LFCR's P/E ratio?

A meaningful P/E ratio is not available for LFCR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is LFCR's price-to-book (P/B) ratio?

LFCR trades at 140.38 times book value per share.

Are insiders buying LFCR stock?

SEC Form 4 filings show no open-market insider buys at Lifecore Biomedical, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

EMBC

Embecta Corp.

$192.5M

ACB

Aurora Cannabis Inc.

$203.3M

DERM

Journey Medical Corporation

$171.5M

OGI

Organigram Global Inc.

$163.3M

ASRT

Assertio Holdings, Inc.

$151.4M

TKNO

Alpha Teknova, Inc.

$270.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.